We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-2.45%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.1B
AUM Growth
-$4.47B
Cap. Flow
-$3.98B
Cap. Flow %
-39.35%
Top 10 Hldgs %
25.88%
Holding
2,114
New
677
Increased
359
Reduced
350
Closed
725

Top Buys

Rank Stock Value
1
AEE icon
Ameren
AEE
+$161M
2
ETR icon
Entergy
ETR
+$126M
3
DHR icon
Danaher
DHR
+$124M
4
COO icon
Cooper Companies
COO
+$65.6M
5
PPL
PPL Corp
PPL
+$61.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$419M
2
CMS icon
CMS Energy
CMS
+$170M
3
DUK icon
Duke Energy
DUK
+$164M
4
C icon
Citigroup
C
+$124M
5
CVX icon
Chevron
CVX
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 13.02%
2 Utilities 9.78%
3 Financials 9.29%
4 Technology 8.37%
5 Consumer Discretionary 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
2026
United Therapeutics
UTHR
$22B
-5,383
Closed -$1.9M
UTL icon
2027
Unitil
UTL
$970M
-8,147
Closed -$441K
UTZ icon
2028
Utz Brands
UTZ
$1.24B
-24,055
Closed -$377K
UVV icon
2029
Universal Corp
UVV
$1.12B
-31,384
Closed -$1.72M
VALE icon
2030
Vale
VALE
$62.1B
-2,286,577
Closed -$20.3M
VBTX
2031
DELISTED
Veritex Holdings
VBTX
-53,220
Closed -$1.45M
VC icon
2032
Visteon
VC
$2.83B
-53,739
Closed -$4.77M
VCTR icon
2033
Victory Capital Holdings
VCTR
$7.11B
-5,636
Closed -$369K
VCYT icon
2034
Veracyte
VCYT
$3.4B
-114,840
Closed -$4.55M
VEEV icon
2035
Veeva Systems
VEEV
$40.3B
-132,557
Closed -$27.9M
VIR icon
2036
Vir Biotechnology
VIR
$1.65B
-246,833
Closed -$1.81M
VITL icon
2037
Vital Farms
VITL
$454M
-35,491
Closed -$1.34M
VRDN icon
2038
Viridian Therapeutics
VRDN
$2.75B
-25,724
Closed -$493K
VRNS icon
2039
Varonis Systems
VRNS
$4.74B
-12,598
Closed -$560K
VRNT
2040
DELISTED
Verint Systems
VRNT
-233,788
Closed -$6.42M
VRTX icon
2041
Vertex Pharmaceuticals
VRTX
$139B
-22,794
Closed -$9.18M
VSAT icon
2042
Viasat
VSAT
$10.3B
-123,348
Closed -$1.05M
VSXY
2043
Victoria's Secret
VSXY
$6.79B
-131,275
Closed -$5.44M
VTR icon
2044
Ventas
VTR
$47.7B
-163,498
Closed -$9.63M
VYGR icon
2045
Voyager Therapeutics
VYGR
$209M
-65,830
Closed -$373K
VYX icon
2046
NCR Voyix
VYX
$1.09B
-38,391
Closed -$531K
VZ icon
2047
CALL
Verizon
VZ
$205B
-43,900
Closed -$1.76M
VZ icon
2048
Verizon
VZ
$205B
-526,442
Closed -$21.1M
VZ icon
2049
PUT
Verizon
VZ
$205B
-49,300
Closed -$1.97M
WBS
2050
DELISTED
Webster Financial
WBS
-461,131
Closed -$25.7M

Similar funds

Michael Gelband's Q1 2025 Portfolio in Review

As of Q1 2025, Michael Gelband held 2,114 positions worth $10.1B, down 31% from $14.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.98B in Q1 2025, closing 725 positions and reducing 350 holdings. Its most notable exit was CMS Energy, an estimated $170M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8% a quarter earlier, followed by Utilities and Financials.

Against the trend, Michael Gelband opened a new position in Ameren worth $168M.

  • Michael Gelband's largest Q1 2025 buy was Ameren: 1,668,398 shares worth $168M.
  • Michael Gelband added most to Danaher in Q1 2025, an estimated $124M increase.
  • Michael Gelband's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $419M.
  • Michael Gelband fully exited CMS Energy in Q1 2025, selling an estimated $170M.
  • Michael Gelband's ten largest holdings make up 26% of its $10.1B portfolio in Q1 2025.
  • Michael Gelband opened 677 new positions and closed 725 in Q1 2025.
  • Michael Gelband's portfolio value fell 31% quarter-over-quarter to $10.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.